Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
0.675
-0.053 (-7.31%)
At close: Jul 19, 2024, 4:00 PM
0.682
+0.007 (1.04%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $11.86 million as of July 22, 2024. Its market cap has increased by 9.80% in one year.
Market Cap
11.86M
Enterprise Value
3.07M
1-Year Change
9.80%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.20M to $11.86M, a decrease of -95.71%. That is a compound annual growth rate of -49.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 11.80M | 131.37% |
| Dec 29, 2023 | 5.10M | -83.28% |
| Dec 30, 2022 | 30.50M | -24.50% |
| Dec 31, 2021 | 40.40M | -42.37% |
| Dec 31, 2020 | 70.10M | -59.48% |
| Dec 31, 2019 | 173.00M | -37.36% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 13.40M |
| NEXGEL | 13.08M |
| Avalo Therapeutics | 12.94M |
| Silo Pharma | 12.79M |
| Addex Therapeutics | 12.66M |
| STRATA Skin Sciences | 12.48M |
| Guardion Health Sciences | 12.32M |
| RedHill Biopharma | 12.25M |